FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
With the last issue of UroToday International Journal for 2013, we want to wish all our readers and reviewers a happy holiday and a prosperous New Year 2014! We have received a large number of interesting articles and case reports throughout the year and we want to thank all of the authors for their contributions to another successful year for the UIJ.
An article by Kosilov et al. presents a study looking at the performance management of the long-term results of treatment of overactive bladder (OAB) in elderly men. They found that an additional cycle of treatment with a combination of high-dosed trospium and solifenacin, conducted 2 months after the primary treatment, significantly decreased the probability of recurring OAB in elderly men during 1 year, with low-level side effects.
Logan et al. evaluated whether omission of a pelvic lymphadenectomy (PLND) in patients with D’Amico low-risk prostate cancer was associated with increased rates of 5-year biochemical recurrence (BCR). With a 43-month median follow-up, D’Amico low-risk prostate cancers are no more likely to develop BCR when limited PLND is omitted than those who undergo limited PLND.
An evaluation of the performance of C11-Acetate positron emission tomography/computed tomography (PET/CT) in recurrent prostate cancer patients with early and late imaging was performed by Almeida et al. They found that early imaging appears optimal in the evaluation of recurrent prostate adenocarcinoma. In a larger application (300 patients) of early imaging in this patient population, C11-Acetate PET/CT demonstrates a consistently high detection rate.
An article by Cornfield describes in detail the 4-year effort of the Knock Foundation and its volunteers in bringing modern urologic procedures, specifically cystoscopy, transurethral resection/vaporization of the prostate, and visual internal urethrotomy, to previously underserved areas of Kenya and Ethiopia, teaching techniques to local physicians and building sustainable, if nascent, programs in urology at distinct institutions.
Finally, Shchukin et al. investigated the sources of bleeding from the lumen of the inferior vena cava during removal of the tumor thrombus and they concluded that the variant lumbar veins rarely are the main source of bleeding during thrombectomy.
We also present a series of case studies that include various topics, including Isolated Primary Megalourethra, Management of Intravesical Magnetic Beads, Neobladder Vaginal Fistulae, Metanephreic Adenoma of the Kidney, Second Allografted Kidney, Page Kidney Phenomenon, and Fracture of the Penis.
I personally want to thank the authors and reviewers for their valuable contributions to this issue.